Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3742253013 | Poractant alfa only product in pulmonary dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3742254019 | Product containing only poractant alfa in pulmonary dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4617511000052112 | läkemedel som endast innehåller poraktant alfa, pulmonell läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
4703271000052115 | läkemedel som endast innehåller porcina lunglipider och protein, pulmonell läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Poractant alfa only product in pulmonary dose form | Is a | Product containing only poractant alfa (medicinal product) | true | Inferred relationship | Some | ||
Poractant alfa only product in pulmonary dose form | Is a | Poractant alfa-containing product in pulmonary dose form | true | Inferred relationship | Some | ||
Poractant alfa only product in pulmonary dose form | Has manufactured dose form | Pulmonary dose form (dose form) | true | Inferred relationship | Some | ||
Poractant alfa only product in pulmonary dose form | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
Poractant alfa only product in pulmonary dose form | Has active ingredient | Poractant alfa (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Poractant alfa 80 mg/mL suspension for endotracheopulmonary instillation | Is a | True | Poractant alfa only product in pulmonary dose form | Inferred relationship | Some |
This concept is not in any reference sets